ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Established For Non-Sterile API and Pharmaceutical Intermediates, Ningxia Taiyicin Biotech Co., LTD.
December 30, 2021Ningxia Taiyicin founded in 2010, covering about 221.73 hectares of construction area with registered capital RMB 625 million, is mainly established for Non-sterile API and pharmaceutical intermediates. -
Analysis of Current Situation of Erythromycin: How will It Develop?
September 30, 2017Erythromycin is one of the most popular bulk APIs in China export. This article analyzes Erythromycin market, price changes, Capacity, and market forecast.
Pharma Sources Insight January 2025
